Home | Contact |
5/15/13 - Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders
4/3/13 - Atlanta can become Silicon Valley of biotechnology (Transcript) (Advisory)
3/5/13 - Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis
Read More...
March 11, 2013 Galectin Therapeutics Corporate Summary
Galectin rings NASDAQ closing bell
